Literature DB >> 8666838

Limitations on the use of dihydrorhodamine 123 for flow cytometric analysis of the neutrophil respiratory burst.

L J van Pelt1, R van Zwieten, R S Weening, D Roos, A J Verhoeven, B G Bolscher.   

Abstract

Intracellular oxidation of dihydrorhodamine 123 (DHR) to the fluorescent compound rhodamine 123 (Rho123) was used to detect the production of oxygen metabolites in activated neutrophils. Total leukocyte preparations can be used in this assay, which is a great advantage when priming of the respiratory burst is studied. We have defined the conditions that should be taken into account when priming is studied with this assay. We found that neither the extent nor the kinetics of DHR oxidation match those of NADPH oxidase activity. In addition, DHR oxidation is influenced by the absolute and relative number of neutrophils in the leukocyte suspension, by the DHR concentration and by myeloperoxidase availability. The results presented in this study emphasize the need for carefully designed experiments when DHR is used to study the respiratory burst in neutrophils.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666838     DOI: 10.1016/0022-1759(96)00024-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

1.  Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.

Authors:  J E Hughes; J Stewart; G R Barclay; J R Govan
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  Molecular diagnosis of chronic granulomatous disease.

Authors:  D Roos; M de Boer
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

3.  Rapid genetic analysis of x-linked chronic granulomatous disease by high-resolution melting.

Authors:  Harry R Hill; Nancy H Augustine; Robert J Pryor; Gudrun H Reed; Joshua D Bagnato; Anne E Tebo; Jeffrey M Bender; Brian M Pasi; Javier Chinen; I Celine Hanson; Martin de Boer; Dirk Roos; Carl T Wittwer
Journal:  J Mol Diagn       Date:  2010-03-12       Impact factor: 5.568

4.  Complement receptor 3 and Toll-like receptor 4 act sequentially in uptake and intracellular killing of unopsonized Salmonella enterica serovar Typhimurium by human neutrophils.

Authors:  Robin van Bruggen; Debby Zweers; Angela van Diepen; Jaap T van Dissel; Dirk Roos; Arthur J Verhoeven; Taco W Kuijpers
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

5.  Flow cytometric evaluation of leukocyte function in rat whole blood.

Authors:  Wen Li; S C Sydney Chung
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Nov-Dec       Impact factor: 2.416

6.  Role of Flow Cytometry in the Diagnosis of Chronic Granulomatous Disease: the Egyptian Experience.

Authors:  Rabab El Hawary; Safa Meshaal; Caroline Deswarte; Nermeen Galal; Mahitab Abdelkawy; Radwa Alkady; Dalia Abd Elaziz; Tomas Freiberger; Barbora Ravcukova; Jiri Litzman; Jacinta Bustamante; Jeannette Boutros; Taghrid Gaafar; Aisha Elmarsafy
Journal:  J Clin Immunol       Date:  2016-05-24       Impact factor: 8.317

7.  Involvement of Fcgamma receptors and beta2 integrins in neutrophil activation by anti-proteinase-3 or anti-myeloperoxidase antibodies.

Authors:  D Reumaux; T W Kuijpers; P L Hordijk; P Duthilleul; D Roos
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

8.  Inherited p40phox deficiency differs from classic chronic granulomatous disease.

Authors:  Annemarie van de Geer; Alejandro Nieto-Patlán; Douglas B Kuhns; Anton Tj Tool; Andrés A Arias; Matthieu Bouaziz; Martin de Boer; José Luis Franco; Roel P Gazendam; John L van Hamme; Michel van Houdt; Karin van Leeuwen; Paul Jh Verkuijlen; Timo K van den Berg; Juan F Alzate; Carlos A Arango-Franco; Vritika Batura; Andrea R Bernasconi; Barbara Boardman; Claire Booth; Siobhan O Burns; Felipe Cabarcas; Nadine Cerf Bensussan; Fabienne Charbit-Henrion; Anniek Corveleyn; Caroline Deswarte; María Esnaola Azcoiti; Dirk Foell; John I Gallin; Carlos Garcés; Margarida Guedes; Claas H Hinze; Steven M Holland; Stephen M Hughes; Patricio Ibañez; Harry L Malech; Isabelle Meyts; Marcela Moncada-Velez; Kunihiko Moriya; Esmeralda Neves; Matias Oleastro; Laura Perez; Vimel Rattina; Carmen Oleaga-Quintas; Neil Warner; Aleixo M Muise; Jeanet Serafín López; Eunice Trindade; Julia Vasconcelos; Séverine Vermeire; Helmut Wittkowski; Austen Worth; Laurent Abel; Mary C Dinauer; Peter D Arkwright; Dirk Roos; Jean-Laurent Casanova; Taco W Kuijpers; Jacinta Bustamante
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

9.  Clinical Features of Female Taiwanese Carriers with X-linked Chronic Granulomatous Disease from 2004 to 2019.

Authors:  Wen-I Lee; Cheng-Hsun Chiu; Chao-Yi Wu; Yi-Ching Chen; Jing-Long Huang; Li-Chen Chen; Liang-Shiou Ou; Tsung-Chieh Yao; Tang-Her Jaing; Shih-Hsiang Chen; Chi-Jou Liang; Chen-Chen Kang
Journal:  J Clin Immunol       Date:  2021-05-08       Impact factor: 8.317

10.  Rare duplication or deletion of exons 6, 7 and 8 in CYBB leading to X-linked chronic granulomatous disease in two patients from different families.

Authors:  Marie José Stasia; Karin van Leeuwen; Martin de Boer; Cecile Martel; Michele Mollin; Isabelle Thuret; Gerard Michel; Celine Hanson; Nancy H Augustine; Charles Coutton; Véronique Satre; Carl T Wittwer; Harry Hill; Dirk Roos
Journal:  J Clin Immunol       Date:  2012-03-02       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.